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1. Introduction 
In vascular surgery during the manipulation on the vessels the periferial tissues always 
suffer from a more or less severe ischaemia. In acute ischaemia the time of ischaemia could 
be also serious, thus after reconstruction we always have to face with reperfusion injury. 
The aim to reduce these extent of these reperfusion injury associated pathways has real 
clinical importance in vascular surgery. 
Reperfusion injury is an inherent response to the restoration of blood flow after ischaemia, 
and is initiated at the very early moments of reperfusion, lasting potentially for days. The 
extent of the oxidative stress and the consecutive generalized inflammatory response 
depends on the ischaemic-time, the ischaemic tissue volume, and the general state of the 
endothelium-leukocyte-tissue functional complex (diabetes, chronic ischaemia, drugs). The 
pathogenesis of reperfusion injury is a complex process involving numerous mechanisms 
exerted in the intracellular and extracellular environment.  
2. Pathophysiology of reperfusion injury 
Reperfusion injury is not a mere worsening of the ischaemia-induced damage, but it is 
secondary to events that are specifically induced by reperfusion. In fact, reperfusion injury 
is due to complex mechanisms involving mechanical, extra-cellular and intracellular 
processes. The modern hypothesis of the pathogenesis of reperfusion injury has been 
reviewed by Piper and al.1 In patients with acute periferial ischaemia, it is now widely 
accepted that periodically reopening the occluded artery is accompanied by a reduction of 
the extent of necrosis and a major reduction of short- and long-term mortality. However, 
together with a definite protective effect on ischaemic tissues, post-ischaemic reperfusion 
may bring with it unwanted consequences that may partly counteract its beneficial effects. 
This phenomenon has thus been named reperfusion injury.  
2.1 Causes of reperfusion injury  
It seems that in the tissue ischaemia/reperfusion (I/R) can induce various forms of cell 
death, such as programmed cell death, apoptosis, oncosis and necrosis2. Apoptosis can be 
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caused by both prolonged ischaemia/hypoxia and by reperfusion3. In contrast to 
programmed cell death, apoptosis and oncosis, which are pre-mortal processes, necrosis is a 
post-mortal event. According to this viewpoint necrosis is not a form of cell death but the 
end stage of  cell death processes.  
The mechanisms of reperfusion-induced cell death are not completely understood, but it 
seems that the occurrence of oxidative stress related to the generation of ROS may play an 
important role4. ROS have downstream effects, which results in the initiation of a highly 
orchestrated acute inflammatory response through the release of cytokines, activation of 
vascular endothelial cells and leukocytes with expression of cell surface adhesion molecules, 
and up-regulation of a program of pro-inflammatory genes, which contribute to the onset 
and maintenance of post-ischaemic inflammation5. When the occlusion of the artery branch 
that perfuse the ischaemic tissue is removed, the superoxide anion (O2-) production 
increases as a result of the activation of various enzymatic complexes. The superoxide anion 
and other ROS strongly oxidize the myocardial fibres already damaged by the ischaemia, 
thus favouring the apoptosis6. It reacts with the nitric oxide, forming peroxynitrite (ONOO–). 
Therefore, ONOO-, represents a sign of a reduced availability of nitric oxide7 and it 
participates with O2- in the lesion of tissues8. Superoxide anion dependent damages are 
reduced if O2- is transformed to hydrogen peroxide (H2O2) by the superoxide-dismutase. 
However, since in the presence of Fe2+ or Cu2+, the H2O2 can be transformed in hydroxyl 
anion (HO-), which is more toxic than O2- and H2O2, an increase in toxicity can occur. 
Reperfusion injury is also due to cellular Ca2+ overload. The Ca2+-overload, which starts 
during ischaemia, is further increased during reperfusion. 
The overload of Ca2+ increases the cellular osmolarity favouring swelling (explosive 
swelling) of skeletal muscle cells; it can also favour the expression of proapoptotic elements 
from mitochondria9. It is noteworthy that altered cytosolic Ca2+-handling during ischaemia 
may induce structural fragility and excessive contractile activation upon reperfusion, as also 
indicated from a progressive increase of ventricular diastolic pressure and contraction band 
necrosis10. 
Ca2+-overload is also considered to be responsible for the opening of mPTP. Although, 
mPTP opening is strongly inhibited by acidosis during ischaemia, it is favoured by ATP 
depletion, oxidative stress and high intramitochondrial Ca2+ concentrations, conditions all 
occurring during myocardial reperfusion11.  
Intriguingly, the nuclear factor kappa B (NFkB) plays a double-edge sword role in tissue-
protection. Activation of NFkB is essential for late preconditioning, in which NFkB is 
involved in the up-regulation of iNOS and COX-2 genes. However, in the longer time the 
role NFkB is also important in reperfusion injury. It contributes to the exacerbation of the 
tissues lesions sustaining inflammatory reactions. The activation of NFkB is induced from 
several agents included hydrogen peroxide12. NFkB determine an up-regulation of the genes 
responsible of the production of molecules of cellular adhesion. These molecules favour the 
adhesion of leukocytes to the endothelium and possibly the migration within the cells13. 
Moreover, the reduced nitric oxide availability determined by I/R participates to the 
activation of transcription codifying for molecules of cellular adhesion14. Therefore, tissue 
damages during reperfusion among others can be due to the cellular/mitochondrial 
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overload of Ca2+, to the liberation of ROS, to the activation of mPTP, to the reduced 
availability of nitric oxide and to the activation of the NFkB. The nitric oxide deficiency can 
also cause vasoconstriction and formation of micro-thrombi into the lumen of the small 
vessels15. These mechanisms, combined with the adhesion of the leucocytes to the 
endothelium, can lead to the so-called ‘no-reflow phenomenon`16. In summary, reperfusion 
injury is due to several mechanisms that include Ca2+ overload, ROS generation, reduced 
availability of nitric oxide, mPTP opening and to the activation of the NFkB, which lead to 
the augmented expression of molecules of cellular adhesion, leukocyte infiltration and no-
reflow phenomenon. 
3. Effects of reperfusion injury 
Among the outcomes of reperfusion injury are included: (1) endothelial and vascular 
dysfunction and the sequels of impaired arterial flow, which may concur with the ‘no-
reflow phenomenon’; (2) metabolic and contractile dysfunction; (3) arrhythmias in case of 
myocardial I/R; (4) cellular death by cellular swelling, and apoptosis. One may anticipate 
that effective treatment during reperfusion may reduce tissue injury. However, the 
complexity of mechanisms suggests that one single intervention aimed to contrast just one 
or two of these mechanisms may not be sufficient. (Figure 1) 
4. Definition of postconditioning  
The concept of ‘Ischaemic PostC’ was first described by Vinten-Johansen’s group17. This 
study was performed in a canine model of 1 hr coronary occlusion and 3 hrs reperfusion. In 
this study the PostC algorithm was 30 sec. of reperfusion followed by 30 sec. of coronary 
occlusion, which were repeated for three cycles at the onset of reperfusion. Although this 
seminal study used the term ‘Ischaemic PostC’, subsequent studies of these and other 
authors omit the term ‘Ischaemic’ because it is not clear whether the brief periods of 
ischaemia, the preceding and/or the subsequent periods of reperfusion, or their 
combination, provide the key stimulus for cardioprotection. In general, PostC can be 
defined as intermittent interruption of coronary flow in the very early phase of a 
reperfusion, which leads to protection against reperfusion injury. The duration and number 
of these stuttering periods of reperfusion and ischaemia has been one of the aims of early 
studies on this topic. 
5. Protective effects of postconditioning 
Ischaemic PostC was already examined mostly in myocardium, thus the protective effects 
are known in the myocardium. Our study was the first to examine the effect of PostC in 
peripheral tissues. 
Depending on species, models and other factors, PostC reduces the infarct size by ~20–70% 
versus matched controls with matched risk areas. There is an emerging agreement across 
multiple models and species that PostC may reduce endothelial dysfunction and endothelial 
activation, thus leading to a reduced endothelial/leukocyte interaction and to a reduced 
ROS formation. Reduced incidence of apoptosis and arrhythmias has also been observed. 
Whether PostC reduces post-ischaemic stunning it has not yet been clarified. 
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Fig. 1. Simplified presentation of the mechanism of ischaemic-reperfusion injury. 
Emphasizing, that the engine of reperfusion injury is the ROI – cytokine – leukocyte positive 
feedback circle. 
Hypoxia leads to intracellular ATP depletion with a consecutive hypoxanthine elevation. In 
the early seconds of reperfusion, when the molecular oxygen appears in the cell, the - 
xanthine oxidase catalised – hypoxanthine-xanthine conversion will produce a mass of 
superoxide radicals. Superoxide radical and the other reactive oxygen intermediates will 
damage the membrane-lipids (through lipidperoxidation), the proteins (causing enzyme 
defects and ion channel injury) and the DNA. These are the main pathways of the cellular 
oxidant injury. The endogenous antioxidant system defends against these radical injuries. 18 
Reactive oxygen species (ROS) will also induce local and systemic inflammatory responses 
through the inducing of cytokine expression and leukocyte activation. Inflammatory process 
leads to increased microvascular permeability, interstitial edema, and capillary perfusion 
depletion. The oxidative and inflammatory pathways will lead to a complex reperfusion 
injury. 19 (ROI – reactive oxygen intermediers; ATP – adenosine triphosphate; DNA – 
deoxyribonucleic acid) 
6. Reduction of necrosis 
In their seminal study Vinten-Johansen and coworkers 20 reported that PostC causes massive 
salvage of the myocardium. The infarct size was reduced by ~45% when the initial minutes 
of reperfusion were ‘stuttered’ compared to an abrupt and complete reperfusion. These 
findings have been confirmed by several laboratories as well21. As mentioned, in multiple 
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species and models, PostC reduces infarct size by ~20–70% versus matched controls with 
matched risk areas22. Studies from Przyklenk’s laboratory and other laboratories confirmed 
the infarct size reduction in rat isolated heart model23. It has been showed that in hearts 
perfused with constant flow the infarct size reduction by PostC is greater than that observed 
in the same model perfused at constant pressure 24. 
7. Reduction of apoptosis  
Apoptosis is a genetically programmed cell death that occurs in reperfusion injury25. The 
reduction in apoptosis may involve the inhibition of caspase-3 and caspase-9 and 
preservation of Bcl- 2/Bax ratio. So far the only study that reported a reduction of apoptosis 
by PostC is of Zhao et al. 26 in which a reduced apoptosis was detected with TUNEL assay 
and the presence of DNA ladders in a model of isolated neonatal cardiomyocytes that 
underwent hypoxic PostC. We also examined anti- and proapoptotic factors in our periferial 
PostC model. 
8. Reduction of endothelial dysfunction 
The endothelial cell dysfunction is a common characteristic of various heart pathologies27. In 
their seminal study Zhao et al.28 reported that postischaemic endothelial dysfunction was 
attenuated by PostC. In this study, incremental doses of acetylcholine were used to evaluate 
the endothelium dependent vasodilatation of coronary vessels isolated from the post-
ischaemic region. The authors demonstrated that vasodilatation of postconditioned vessels 
was improved with respect to that observed in post-ischaemic control vessels. The 
vasodilator response was similar to that observed in preconditioned vessels and to that 
observed in vessels from non-ischaemic region.  
9. Reduction of endothelial activation and neutrophil adherence  
PostC decreases the expression of P-selectin, an adhesion molecule on the surface of 
endothelial cells. Moreover, it has been observed both a reduction in neutrophils adhesion 
on the post-conditioned coronary artery endothelium and accumulation of neutrophils in 
the area at risk29. A reduction in superoxide anion generation in the perivascular area has 
also been observed in the proximity of risk area of postconditioned hearts30. Whether the 
reduced neutrophil accumulation, the subsequent ROS production and the pro-
inflammatory response is a cause or consequence of necrosis, apoptosis and vascular injury 
is not clear. In fact, PostC exerts marked cardioprotection in leukocyte-free models (isolated 
buffer perfused hearts and isolated cardiomyocytes)31.  
10. Possibilities of postconditioning 
It has been reported that PostC-induced necrosis reduction persists up to 72 hrs32. These are 
important studies because they demonstrate that the protection by PostC represents a long-
term protective effect and not a mere attenuation of event involved in early reperfusion injury. 
In some studies the protocol of classical preconditioning and PostC were combined in order to 
see whether or not the protection by these two protocols was additive, relative to the 
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protection of each protocol alone. The results are inconsistent. In a canine model, Halkos et al. 33 
showed that the combination of protocols is neither additive for infarct size reduction, ROS 
production nor for post-ischaemic endothelial dysfunction. Similar results were obtained by 
Tsang et al. 34 and by us 35 in isolated perfused rat hearts. However, Yang et al. 36 demonstrated 
in an in vivo rabbit model that the combination of the two protocols reduced infarct size 
significantly more than either manoeuvre alone. The different results may be due to species 
difference and/or different I/R and PostC protocols. Recently, Bolli’s group reported that 
cardioprotection induced by late preconditioning is enhanced by PostC via a COX-2-mediated 
mechanism in conscious rats37. It remains to de ascertained whether such additive effect 
between late preconditioning and PostC can be observed in other species and/or models. 
Very few studies tested the differences between male and female hearts with regard to 
PostC effectiveness. In a specifically designed study it has been reported that while the 
PostC protective effect against stunning was observed in isolated male rat hearts after both 
20 min. and 25 min. ischaemia, the protective effect was present in female rat hearts exposed 
to 20 min of ischaemia, but absent in those exposed to 25 min. ischaemia38. In a preliminary 
study, it has been observed that after 30 min. ischaemia the PostC protective effect against 
infarction is less effective in female than in male rat hearts. The importance of PostC 
warrants further studies to elucidate the signal pathways and differences in males and 
female hearts. It has been reported that cardioprotection by PostC is dependent on the PostC 
algorithm in aged and STAT3 (signal transducer and activator of transcription 3)-deficient 
hearts. Moreover it seems that the reduced levels of STAT3 with increasing age may 
contribute to the age-related loss of  PostC protection39. 
In clinical practice ischaemic postconditioning seems even as effective as ischaemic 
preconditioning. Furthermore, PostC could be used after ischaemia, thus it coud be used in 
acute ischaemia as well. Threre are many more details in the pathogenesis and clinical 
applicability of PostC, it seems to be an effective tool in cardiology and vascular surgery to 
reduce reperfusion injury.  
11. Effects of ischaemic postconditioning in human vascular surgery  
11.1 Aims 
Ischaemic postconditioning was found effective to reduce reperfusion injury not only in 
experimental animal models, but in humans as well in cardiac interventions. In our 
investigations we focused on the effect of ischaemic PostC in human revascularization 
operations. After aorto-bifemoral bypass surgery we applied ischaemic PostC and observed 
the protective effect.  
To describe the oxidative stress we measured the serum malondialdehyde level – to 
quantify the rate of lipidperoxidation, and the antioxidant enzymes (SOD, GSH, SH). To see 
the inflammatory changes we measured serum MPO levels, free radical production of 
leukocytes, and the expression of leukocyte CD11a and 18 adhesion molecules. 
11.2 Patients and methods 
Patient selection for this prospective randomized study performed according to the Helsinki 
Declaration (1996), considering the statute of Hungarian Ministry of Health 
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(35/2005.(VIII:26.)) with the permission of local ethical board of the Pécs University Medical 
School (No of permission: 2498). Blood samples were collected in three Vacutainer tube 
containing trisodium citrate (3.8%) and one containing K3-EDTA (7.5%; Becton Dickinson, 
UK; blue or purple, respectively), before, and two and 24 hours, then one week after the 
surgery. All human subjects provided formal informed consent.  
12. Aorto-bifemoral bypass surgery 
In general anaesthesia median laparatomy was performed. After physical examination of 
the abdominal organs we prepared the distal abdominal aorta. Intravenous 7500 IU 
unfractionated heparine was given. After occlusion of the aorta a 3 cm longitudinal 
aortotomy was made. High pressure inflow could be detected from the central aorta. Dacron 
Y-graft (size depending on the diameter of the vessels) proximal end-to-side anastomosis 
was sutured with 4/0 Premilene (polypropilene monophylament, B-Braun Aesculap, 
Tuttlingen, Germany).  
We isolated the common femoral artery and its sidebranches (deep and superficial femoral 
artery). 3 cm longitudinal arteriotomy was made on the common femoral artery. Exploration 
of distal flow was checked Fogarty catheter. The distal branches of Y-graft are tunneled 
under the inguinal ligament, and on both sides an end-to-side anastomosis was performed 
to the common femoral artery with 5/0 Premilene running suture. Followed by haemostasis, 
drain was placed, and the wound was closed. 
All patients completing the study suffered from general atherosclerosis with distal aortic or 
aorto-biiliac occlusion. All patients received antiplatelet therapy (at least 75 mg Aspirin) 
before the recruitment. Low molecular weight heparin was administered in the 
perioperative period. Ten healthy blood donors served as controls for the measurements 
(Control group). The patients with other chronic inflammatory disease, or gangrene were 
excluded from the study. After intragroup analysis the patients with significantly deviating 
results (caused by polytransfusion, extreme intraoperative blood loss, or any postoperative 
complication) we excluded from the study. 
13. Human ischaemic postconditioning protocol 
In the postconditioned group (10 patients) after the completion of the distal anastomosis, 
before starting the reperfusion we made two cycles of 30 sec reperfusion-reocclusion on the 
graft. After this two cycles of reperfusion-reocclusion we let the continuous reperfusion to 
the distal artery. 
In the ischaemia-reperfusion group (10 patients) after the distal anastomosis we started the 
continuous perfusion. 
14. The measurement of oxidative stress parameters 
Measurement of malondialdehyde (MDA):  
Malondialdehyde was determined in anticoagulated whole blood, by photometric method40.  
Measurement of reduced glutathione (GSH) and plasma thiol (SH) groups:  
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GSH and plasma SH levels were determined from anticoagulated whole blood (ethylene 
diamine tetraacetic acid (EDTA)) by Ellman’s reagent according to the method of Sedlak and 
Lindsay41.  
Measurement of Superoxide dismutase (SOD) activity in washed red blood cell (RBC):  
The main principle of this measurement was that adrenaline is able to spontaneously 
transform to adrenochrome (a detectable colorful complex). This transformation can be 
blocked by SOD, and SOD containing cells or tissues. The difference in the rate of rise of 
control and sample curves obtained at 415 nm, are proportional to SOD activity42.  
15. Measurement of inflammatory response, leukocyte activation 
Determination of free radical production from whole blood:  
Free radical production was induced by 30 µl phorbol-12 myristate 13-acetate (PMA; 
0,2µg/ml) (Sigma Aldrich Budapest); in the mixture of whole blood (20 µl), phosphate 
buffered saline (1400 µ) and 50 µl luminol (3.33 µg/ml; Boehringer Mannheim Gmbh 
Germany), and was detected by Chrono-Log Lumino-aggregometer.  
16. Serum myeloperoxidase assay 
Anticoagulated blood was centrifuged with 2000g, and 200 µl plasma was mixed with 1 ml 
working solution (0,1 M sodium-citrate 10,9 ml, 0,05% Triton-X 100 5 µl, 1mM H2O2 1 ml, 
0,1% o-dianisidine 100 µl). The mixture was incubated at 37 ºC for 5 minutes, then 1 ml 35% 
perchloric acid was added. Photometry were done at 560 nm. Plasma myeloperoxidase was 
expressed as nM/l. Hematologic measurement: Red blood cell count, white blood cell count, 
platelet numbers, haemoglobin concentration, haematocrit level were measured by Minitron 
automatic analysator (Diatron Ltd, Budapest, Hungary).  
17. Leukocyte adhesion molecule measurement 
The leukocytes were marked with fluorescein isotiocianide (FITC) labeled antibodies for 
adhesion molecules (CD11, CD11b, CD18, CD49d, és CD97) (Becton Dickinson Biosciences, 
Pharmingen, USA), and measurements were performed on BD FacsCalibur (Becton 
Dickinson Biosciences, Pharmingen, USA) flowcytometer. 43 44 
18. Hematology test 
Red blood cell count, white blood cell count, platelet numbers, haemoglobin concentration 
and haematocrit level were measured by Minitron automatic analysator (Diatron Ltd, 
Budapest, Hungary).  
19. Statistical analysis  
Data are expressed as mean ± SE, or percentage. For analysis of data, paired and unpaired 
Student’s t-test, and one-way analysis of variance (ANOVA) were used. Statistical 
significance was established at p<0.05.  
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20. Results 
Plasma malondialdehyde concentration before surgery was similar to the control group. A 
significant increase was detected in both group right after the reconstruction, but this 
elevation was significantly higher in the non-conditioned group. Same results were 
measured 24 hours later and the MDA plasma concentration decreased to the initial values 
after 7 days. (Figure 2) 
 
Fig. 2. Changes in plasma malondialdehyde concentration in the patients following the 
operations. (#  p<0.05 vs before surgery; *  p<0.05 vs non-conditioned group)  
Measuring the antioxidant enzyme plasma levels we observed that the thiol group 
concentration in non-conditioned group significantly decreased in the early reperfusion 
period. The 24 hours values did not show significant changes compared to control and 
initial values, but after a week in the non-conditioned group a slight decrease was detectable 
(the second waves of reperfusion injury: mediated by not the ischaemia-reperfusion, but the 
inflammatory response activated leukocytes45). 
In the plasma level of reduced glutathion, a significant decrease was detectable in the 
early reperfusion in both groups. From the first day a continuous elevation was observed 
until the 7th day and the plasma level in both groups returned to the values before 
surgery. (Figure 3) 
The activity of superoxide dismutase before surgery was lower in both groups compared to 
the control group, and did not show any changes right after the operation. 24 hours later in 
the non-conditioned group we detected a significant decrease, which disappeared at the end 
of the week. (Figure 4) 
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Fig. 3. Changes in antioxidant compounds (thiol group, reduced glutahtion) plasma levels 
during the examined perioperative period. (# p<0.05 vs before surgery; * p<0.05 vs non-
conditioned group)  
 
Fig. 4. Changes in blood superoxide dismutase activity during the examined perioperative 
period. (# p<0.05 vs before surgery; * p<0.05 vs non-conditioned group)  
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Fig. 5. Changes in the PMA induced free radical production of leukocytes during the 
perioperative period. We demonstrated the result of the speed and the maximum of radical 
production. (# p<0.05 vs before surgery; * p<0.05 vs non-conditioned group)  
Leukocyte activation increased significantly immediately after revascularisation surgery in 
the non-conditioned group, and this elevation could not be observed in the postconditioned 
group. In the late reperfusion period the maximum of leukocyte-derived free radical 
production were elevated in both group withouth significant difference between the two 
groups. (Figure 5) 
The plasma myeloperoxidase (MPO) concentration was higher in both investigated groups 
than in healthy control group. We did not observed any significant changes until the 7th 
day. On the last day of the protocol the plasma MPO concentration elevated significantly in 
the non-conditioned group, and this elevation was not detectable in the postconditioned 
group. (Figure 6) 
Granulocyte surface adhesion molecules were detected by flowcytometer. The detectable 
expression of CD11a adhesion molecules were significantly lower in the postoperative first 
samples than before surgery. There was no significant difference at this time between the 
two groups. After 24 hours in the non-conditioned group a significant expression was 
observed, which was not detected in the postconditioned group. At the end of the one week 
period the values reached the starting values. 
CD18 showed a significant decrease in the immediate reperfusion period in both groups, 
and after these changes were the same as the control values. (Figure 7) 
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Fig. 6. Changes in plasma myeloperoxidase following operation (# p<0.05 vs before surgery; 
* p<0.05 vs non-conditioned group)  
 
Fig. 7. The graphs show the changes in expression of granulocyte adhesion during the 
examined perioperative period. (AU= arbitary unit) (# p<0.05 vs before surgery; * p<0.05 vs 
non-conditioned group)  
0,2 
0,4 
0,6 
0,8 
1,0 
nmol/ml 
Before surgery After surgery 24 hours 7 days 
PLASMA MYELOPEROXIDASE 
(MPO) CONCENTRATION 
CONTROL
RECONSTRUCTION 
RECONSTRUCTION + 
POSTCONDITIONING 
*
#
1,2 
control 
EXPRESSION OF GRANULOCYTE ADHESION MOLECULES 
AU 
100 
200 
300 
400 
500 
# # 
control 
Before 
surgery 
After 
surgery 
24 
hours 
7 days 
Granulocyte CD18 expression 
 
control 
reconstruction 
Granulocyte CD11a expression 
AU 
200 
400 
600 
800 
# 
kontroll 
Before 
surgery 
After 
surgery 
24 
hours 
7 days 
1000 
1200 
1400 
1600 
# 
*
# 
Reconstruction + 
postcond 
www.intechopen.com
Ischaemic Postconditioning 
Reduces Reperfusion Injury After Aortic Revascularization Surgery 
 
249 
In the results of the red blood cell count, white blood cell count, platelet numbers, 
haemoglobin concentration and haematocrit level we did not detected any difference 
between the two groups of patient.  
21. Discussion 
In the last 3 years the literature of ischaemic postconditioning exponentially increased in the 
experimental cardiology. The beneficial effects of the manoeuver has been confirmed in 
various models, including human results as well, and the cellular and biochemical 
background is intensively examined. Until now this is the first study to evaluate the effect of 
ischaemic postconditioning on peripheral tissues in abdominal aortic surgery.  
Our results demonstrated that after a prolonged ischaemia, postconditioning can reduce free 
radical production, TNF-alpha expression and leukocyte activation in the early phase of 
reperfusion in an animal model of abdominal aortic surgery. In this model we also 
confirmed that PostC could induce antiapoptotic signaling pathways in the skeletal muscle 
and in far organs as well.  
In our human model we could confirm that ischaemic PostC could decrease in some points 
the revascularization surgery evoked oxidative stress and inflammatory response. 
We have demonstrated that the protective effect of postconditioning is a complex process, 
involving many cell types, the generation of oxidants, cytokines, and inflammatory 
pathways, has not only one target, but acts on a diverse site. This complexity, the powerful 
protective effect and the simplicity in the surgery (lasts for a few minutes) can make the 
manoeuver really a powerful tool of surgeons.   
22. Mechanisms involved in postconditioning 
The mechanisms of protection by PostC were initially attributed mainly to improved 
endothelial function and to the events reducing the detrimental effects of lethal 
reperfusion injury, such as reduced edema, reduced oxidative stress, reduced 
mitochondrial calcium accumulation, reduced endothelium damage and reduced 
inflammation. However, subsequent studies suggest that protection is mediated through 
the recruitment of signal transduction pathways as in the case of ischaemic 
preconditioning. Therefore, a distinction in passive and active mechanisms can  
be proposed. Of course an intricate cross-talk among these events/mechanisms exists, 
thus this distinction can be useful for a better understanding of the phenomenon, but we 
must not forget that a single event/mechanism may not be effective if it occurs alone. 
(Figure 8) 
23. Passive mechanisms 
Among passive mechanisms we can consider those strictly related with hydrostatic force – 
hereafter named as ‘Mechanical mechanisms’ – and those related with reduced endothelial 
adhesion of leucocytes and subsequent reduction of inflammatory process that we call 
‘Cellular mechanisms’. 
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Fig. 8. A schematic figure on the mechanisms of ischaemic postconditioning. 
24. Mechanical mechanisms 
With regard to mechanical or haemodynamic mechanisms, it has been suggested that the 
stuttering of reperfusion and pressure during PostC manoeuvres may limit the hydrostatic 
forces in a very important moment, thus limiting early edema and consequent damages. In 
experiments performed in isolated heart models, the effect of the PostC on the infarct area 
has been studied perfusing the hearts either with constant pressure or with constant flow. It 
has been compared the role of these two types in perfusion in affecting the infarct area 
during PostC. In the constant pressure model the infarct area was less reduced by PostC 
than it was with the model of the constant flow reperfusion after PostC46. Considering that 
during the short period of restoration of flow in the PostC manoeuvres the capillary 
pressure increases less in the constant flow model, than in the constant pressure model (i.e. 
at the beginning of reperfusion in the constant flow model there is smaller hydrostatic 
pressure and so smaller transcapillary pressure), it was argued that in the constant-flow 
model a reduced edema and consequent reduced damages may explain the increased 
effectiveness of PostC. In other words, in the constant flow model the effectiveness of PostC 
is greater than in the constant pressure model supports the idea that the reduction of 
hydrostatic forces during PostC manoeuvres may play an important role in determining the 
protective effects. 
25. Cellular mechanisms 
Among the cellular mechanisms we consider acute inflammatory response. It occurs 
through the release of cytokines, activation of vascular endothelial cells and leukocytes with 
expression of cell surface adhesion molecules, and up-regulation of a program of 
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proinflammatory genes. PostC delays the onset and reduces the maintenance of post-
ischaemic inflammation47. As stated before, whether this is a cause or an effect of PostC 
protection remains to be elucidated. 
26. Active mechanisms (intracellular mechanisms) 
Studies have identified a signalling pathway that is recruited at the time of reperfusion and 
which is similar in ischaemic preconditioning and PostC. This pathway includes the 
survival kinases phosphatidylinositol 3-kinase (PI3K)-Akt and Erk1/2, the major 
components of the reperfusion-injury salvage kinase pathway, termed the RISK- pathway, 
which may influence the mPTP, a non-specific pore of the mitochondrial membrane whose 
opening in the first few minutes of myocardial reperfusion promotes cell death48. Delayed 
washout of endogenously produced adenosine and activation of the adenosine receptor also 
seems to be required for PostC protection49,  by activating the survival pathway. 
Thus delayed washout of adenosine in the setting of PostC might recruit RISK at the time of 
reperfusion through the activation of adenosine responsive G-protein-coupled receptors. It 
seems that adenosine receptors are repopulated during PostC manoeuvres. While in murine 
hearts adenosine A2a and A3 subtypes 50 have been seen to be involved, in rabbit hearts 
PostC seems to depend on A2b subtype 51. An important role of the redox environment has 
also been observed52.  
Therefore, similar to preconditioning, PostC has been proposed to be triggered by receptor 
stimulation, mediated by one or more complex and interrelated signal transduction 
pathways, and, ultimately, achieved via phosphorylation of one or more end-effectors of 
cardioprotection53. 
27. Triggers of postconditioning 
Ligands, such as adenosine 54 and bradykinine 55 what accumulate during PostC 
manoeuvres may initiate the cascade that lead to PostC protection. It has been recently 
reported that inhibition of opioid receptors with opioid antagonists administered 5 min. 
before reperfusion in the absence or presence of PostC, reversed the infarct sparing effect of 
PostC in an in vivo rat model56. The activation of protein kinase C and G (PKC and PKG) 
and opening of mitochondrial KATP channels after PostC (see below) would be consistent 
with the involvement of BK and endogenous opioids. Nitric oxide and ROS may be 
included among the triggers. Nitric oxide is demonstrated to act both as a trigger and as a 
mediator of the preconditioning response in a variety of species. The role of endogenous NO 
in classic ischaemic preconditioning was controversial. Cohen and Downey’s group 
suggested that exogenously administered NO could trigger the preconditioned state 
through a free radical-mediated process not shared by endogenous NO. Very recently these 
authors questioned whether their observation was due to a bias in the experimental model. 
These authors are now on the opinion that endogenous NO participates in triggering in vivo 
preconditioning57. Among the autocaids released by the ischaemic heart there is BK that 
may induce nitric oxide release (Figure 3). It has been suggested that the mechanism 
whereby NO protects myocardium includes the activation of guanylate-cyclase58. As an 
inducer of the protection, nitric oxide may also directly open the mitochondrial KATP 
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channels59. Therefore, nitric oxide acting on mitochondria may play a relevant role in 
protection both through activation of these channels and via modulation of respiratory 
chain; both mechanisms favor ROS signalling, which can trigger protection60. A relevant role 
of nitric oxide may also be attributed to the endothelial protection brought by this molecule 
61 or to its role as antioxidant under certain conditions 62. 
The one-electron-reduction product of nitric oxide, HNO/NO– (nitrosyl hydride/nitroxyl 
anion), has been scarcely studied in an I/R scenario. In our laboratory low doses of 
Angeli’s salt, a donor of HNO/NO–, have been seen to induce early/classical 
preconditioning against myocardial damages63. Intriguingly, the protective effects of 
HNO/NO– generated by Angeli’s salt were more potent than the protective effects 
induced by equimolar concentration of the pure nitric oxide donor diethylamine/nitric 
oxide (DEA/NO). While the HNO/NO– donor seems deleterious in reperfusion64, there is 
evidence that NO may also be involved in the cardioprotection by ischaemic PostC. When 
the nitric oxide synthase (NOS) inhibitor N-omega-nitro-L-arginine methyl esther 
(LNAME) was given 5 min. before start of reperfusion of in vivo rabbit hearts, the infarct 
limiting effect was abolished65. We have shown that nitric oxide participates in PostC, but 
NOS inhibitors given for the entire reperfusion period only blunted the protective effect 
of PostC66 . Paradoxically, the same inhibitor, given only during PostC manoeuvres 
completely blocked the protective effects67. At the moment, we do not have an 
explanation for this apparent paradox. In a previous study, we argued that nitric oxide 
may be produced in post-conditioned heart both by NOS and by non-enzymatic 
mechanisms. Nitric oxide can then activate the guanyl cyclase to produce cyclic guanosine 
monophosphate (cGMP), which mediates protection 68 (see also below). The infusion of a 
NOS inhibitor only during PostC manoeuvres may alter the equilibrium between ROS 
and nitric oxide thus leading to the production of the wrong kind of radical which does 
not trigger the protective pathway. It can be argued that in the absence of this protection 
the stronger limitation of nitric oxide production by NOS may be protective during 
reperfusion. In fact, data have demonstrated that NOS inhibitors can attenuate I/R 
damage69. Also, the different doses of nitric oxide inhibitors applied and the different 
basal levels of nitric oxide endogenously produced may explain these disparities.  
The beneficial and deleterious effects of nitric oxide and nitrite in pathophysiological 
conditions and contradictory results about the effects of nitric oxide during reperfusion 
have been reviewed by Bolli in 200170, Wink et al. in 200371, Pagliaro in 200372 and Schulz 
et al. in 2004 73. ROS could also be included among the triggers of  PostC. In fact, ROS 
scavengers such as N-acetylcysteine and 2-mercapto-propionylglycine given during PostC 
manoeuvres prevent the protective effects74. It is possible that the low pH during the 
PostC cycles prevents mPTP opening, while the intermittent oxygen bursts allow 
mitochondria to make enough ROS in a moment in which other enzymes, able to produce 
massive quantity of ROS, are not yet re-activated. Then mitochondrial ROS may activate 
PKC and put the heart into a protected state. The importance of the role of acidosis in the 
triggering of PostC protection has been recently confirmed by two independent 
laboratories75. Acidosis may also prevent mPTP opening in the early reperfusion (see 
below). Recently, it has been reported that redox signaling and a low pH at the time of 
myocardial reperfusion are also required to mediate the cardioprotection triggered by 
ischaemic preconditioning76.  
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28. Mediators of postconditioning 
We considered ROS among triggers as they are necessary during PostC manoeuvres. 
Nevertheless, PostC activated the RISK pathway, with increased expression of the 
phosphorylated form of endothelial nitric oxide synthase (eNOS) as one of the results77. 
Thus it is likely that after NOS activation the cGMP is produced and PKG is activated; then 
mitochondrial ATP-dependent potassium (mKATP) channels are opened and ROS produced. 
Therefore cGMP, PKG, mKATP and ROS may be considered as mediators of PostC 
protection, which are likely to be upstream to PKC activation. We demonstrated that cGMP 
production is increased during reperfusion of postconditioned hearts78. Moreover we 
showed that in these hearts mKATP and PKC must also be active (i.e. they should not be 
blocked) during late reperfusion79. Regarding the role of mKATP channels a couple of papers 
indicate that the mKATP channel is important for PostC80. In these studies two different 
mKATP channel blockers (glibenclamide and 5-hydroxidecanoate) abolished the protective 
effect of PostC 81.  
It is interesting that many of the RISK elements (e.g. PI3K/Akt and MEK1/2-ERK) involved 
in the signaling pathway in preconditioning and protection against reperfusion injury have 
recently been documented also in PostC82. Some differences, however, may exist between 
pre- and PostC (see also Table 1 and Table 2). Darling et al. 83 showed an increase of 
phospho-ERK, but not of PI3K/Akt in PostC, while Yang et al.84 showed that ERK is 
involved in PostC, but not in preconditioning. These findings may explain a certain degree 
of additive protection between ischaemic preconditioning and PostC, as observed by Yang 
et al.85. Yet in contrast with Yang et al.86, Cao et al.87 reported that ERK is present in 
preconditioning trigger pathway. The reasons for the differences are not clear. Different 
species and/or protocols may play a role88. Different methods of tissue sampling also be 
may play a role89. Besides protein kinase C, the possible roles for tyrosine kinase, and 
members of the MAPK family other than ERK1/2 in PostC has been suggested90. (Figure 9) 
Focal disorganization of gap junction distribution and down-regulation of connexin 43 
(Cx43) are typical features of myocardial remodelling 91 and Cx43 – especially Cx43 
localized in mitochondria – has been indicated as one key element of the signal transduction 
cascade of the protection by preconditioning. However, Cx43 does not seem to be important 
for infarct size reduction by PostC 92. These results, together with the above reported 
differences on kinase activation by pre- and PostC, suggest a certain degree of differences 
between the protective pathways activated by these two procedures.  
29. End-effectors of postconditioning 
Mitochondrial PTPs opening represents a fundamental step of reperfusion injury. Among 
the potential mechanisms responsible for mPTP opening during reperfusion, Ca2+-overload 
has received particular attention. In particular, mitochondrial Ca2+-overload occurring 
during ischaemia must bring mitochondria closer to the threshold at which mPTP opening 
takes place, favouring the occurrence of mPTP opening during reperfusion, a phenomenon 
described as mitochondrial priming93. Additionally, reduced mitochondrial Ca2+ overload 
during ischaemia has been pointed out as a potentially important mechanism of ischaemic 
and pharmacological preconditioning94. 
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Fig. 9. Possible contexts in the activation of reperfusion injury survival kinases in ischaemic 
postconditioning 
Neonatal rat cardiomyocytes subjected to 3 hrs of hypoxia and 6 hrs of re-oxygenation, 
“hypoxic PostC” with alternating exposure to three cycles of 5 min. hypoxic and normoxic 
conditions preceding re-oxygenation reduced intracellular and mitochondrial Ca2+ loading 
compared to non-postconditioned cardiomyocytes. This was associated with a reduction in 
cardiomyocyte death assessed by propidium iodide and lactate dehydrogenase release95. 
However, the signalling pathways and physiological consequences of this lower 
intracellular Ca2+ by PostC are not known at present, especially in vivo. For instance, it 
cannot be excluded that reduced mitochondrial Ca2+ overload could actually be a 
consequence of a more preserved Ca2+ handling by the sarcoplasmic reticulum in 
postconditioned cardiomyocytes rather than a cause of protection. It has been reported that 
PostC reduces calcium-induced opening of the mPTP in mitochondria isolated from the 
myocardial area at risk96. PostC was also associated with a reduction in infarct size after 
both acute and long-term (72 hrs) reperfusion. Bopassa et al.97 demonstrated in isolated 
perfused rat hearts that maintenance of mPTP closure was associated with PI3K activation, 
which is consistent with the activation of survival kinase pathways described above, but the 
functional involvement of these pathways and regulation of the mPTP in vivo is not yet 
clear. It seems that in the PostC scenario the inhibition of GSK3 contributes to the prevention 
of mPTP opening98. Taken together it would appear that the trigger pathway for PostC 
involves the following sequence of events: occupation of surface receptors (adenosine and  
NOS and non-enzymatic processes to make nitric oxide, activation of cGMP-dependent 
kinase (PKG), opening of mKATP, production of ROS and finally activation of PKC and 
MAPKs as well as inhibition of GSK3 which put the heart into a protected state. The protect 
state may include a central role of the prevention of mPTP opening by acidosis in the early 
phase and by the aforementioned mechanisms in the late reperfusion (Figures 2 and 3).  
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30. Cytoprotection by pre- and postconditioning is redox-sensitive 
It has been already established that preconditioning triggering, that is the period that precedes 
the index ischaemia, is redox sensitive. This was demonstrated by both avoiding 
preconditioning with ROS scavengers and inducing preconditioning with ROS generators 
given before the index ischaemia 99. Also, several metabolites, including acetylcholine, BK, 
opioids and phenylephrine, trigger preconditioning-like protection via a mKATP-ROS 
dependent mechanism100. As stated in the case of reperfusion injury, ROS are also implicated 
in the sequel of myocardial reperfusion injury101. These studies supported the paradigm that 
ROS may be protective in pre-ischaemic phase, but are deleterious in the post-ischaemic phase. 
Thus the main idea was that ROS play an essential, though double-edged, role in 
cardioprotection: they may participate reperfusion injury or may play a role as signaling 
elements of protection in pre-ischaemic phase102. The importance of ROS signalling (as 
opposed to excess ROS in the development of injury) has been examined closely in great detail 
in recent years103. Intriguingly, and in contrast to the above-described theory of ROS as an 
obligatory part of reperfusion induced damage, some studies suggest the possibility that some 
ROS species at low concentrations could protect ischaemic hearts104. Yet, from the above 
reported mechanisms of PostC, it appears that also ischaemic PostC is a cardioprotective 
phenomenon that requires the intervention of redox signaling to be protective105. Moreover, as 
mentioned, very recently it has been shown that redox signalling is also required at the time of 
myocardial reperfusion to mediate the cardioprotection elicited by ischaemic 
preconditioning106. Therefore, the role of ROS in reperfusion may be reconsidered as they are 
not only deleterious. This fact may help to understand the variability in the results of studies 
aimed at proving a role of ROS in reperfusion injury. For instance, negative results came 
from trials in which free radical scavengers such as recombinant human superoxide 
dismutase or vitamin E were administered to patients with coronary artery disease or risk 
factors for cardiovascular events107. In addition to the dual role of ROS (beneficial versus 
deleterious), among the reasons why these scavengers did not show any consistent benefit 
in these human studies may be: (1) the type of ROS generated (e.g. superoxide dismutase 
only removes the superoxide and not the hydroxyl radical); (2) the site of ROS generation 
(e.g. most scavengers scarcely enter into the cells) and (3) the rate of reaction between two 
ROS and/or scavengers. The importance of the rate of reaction can be understood if we 
consider that, despite a five times lower concentration of nitric oxide with respect to 
superoxide dismutase, 50% or more of the available superoxide will react with nitric oxide 
to form ONOO– instead of reacting with superoxide dismutase108. Notwithstanding the 
evidence of a protective role of ROS signalling in reperfusion, we were unable to reproduce 
cardioprotection with ROS generation by purine/xanthine oxidase given at reperfusion109.  
Since ROS scavengers (N-acetyl-L-cysteine or 2-mercapto-propionylglycine), given at the 
beginning of reperfusion, abolished both IP- and PostC-induced protection110 it is likely that 
the type, the concentration and/or the compartmentalization of ROS may play a pivotal role 
in triggering protection at reperfusion time. We are performing studies in the attempt to 
clarify this issue.  
31. Conclusion 
Postconditioning has the advantage of being a way to influence and modify reperfusion 
injury after it has occurred. This may open a therapeutic alternative in situations of 
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unexpected and uncontrolled ischaemic-reperfusion injury, for instance in the situation 
where technical complications occur during surgery, making a simple procedure into a 
complicated one, and making aortic cross-clamping longer than anticipated.  
We think, that many more examinations are needed to describe and understand in details 
the mechanism of ischaemic PostC. We are sure, that this manoeuver is easy to perform, 
quick, and does not any expensive instruments, so it may have a place in the therapeutic 
arsenal of vascular surgeons. 
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